Caption Management, LLC Fate Therapeutics Inc Put Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 11, 2022	SELL	$47.84 - $64.34 $1.44 Million - $1.93 Million	-30,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$67.25 - $92.52 $2.02 Million - $2.78 Million	30,000 New	30,000 $2.6 Million
Q1 2021 May 17, 2021	SELL	$72.16 - $117.4 $1.76 Million - $2.86 Million	-24,400 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$38.09 - $100.95 $929,396 - $2.46 Million	24,400 New	24,400 $2.22 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $220M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.